Description
Product Overview
IGF-1 LR3 1mg is a synthetic recombinant polypeptide analog composed of a modified amino acid sequence to enhance molecular stability and bioavailability under experimental conditions. The compound is manufactured under strict laboratory standards to achieve high purity and sequence fidelity, ensuring consistency in research studies involving protein chemistry and cellular signaling analysis. For Research Use Only. Not for human or veterinary use.
Key Features
- Synthetic polypeptide analog designed for laboratory and biochemical research
- High-purity material validated by HPLC and mass spectrometry
- Sequence-verified for structural accuracy and reproducibility
- Lyophilized formulation ensures extended stability and easy reconstitution
Specifications
- Compound Type: Synthetic Recombinant Polypeptide
- Sequence: Modified 83-amino-acid analog of human IGF-1 (Long Arg³ variant)
- Form: Lyophilized Powder
- Concentration: 1mg per vial
- Purity: ≥99% (HPLC)
- Molecular Formula: C₄₀₀H₆₂₅N₁₁₁O₁₁₅S₉
- Molecular Weight: Approx. 9117 Da
- Appearance: White to off-white powder
Storage and Stability
- Store at -20°C in a sealed, moisture-free container
- Protect from light, humidity, and repeated freeze–thaw cycles
- Allow vial to reach ambient temperature before opening to prevent condensation
- Reconstituted solutions should be used promptly or stored refrigerated under sterile conditions
Intended Use
This material is intended solely for scientific and laboratory research purposes. It is not approved for human or veterinary use and must not be utilized in diagnostic, clinical, or therapeutic applications. Handling should be performed only by qualified research personnel following standard laboratory safety and compliance protocols. For Research Use Only.
